207681-67-2

Basic information

• Product Name: 3-BROMO-N-METHOXY-N-METHYLBENZAMIDE
• Synonyms: 3-BROMO-N-METHOXY-N-METHYLBENZAMIDE
• CAS NO: 207681-67-2
• Molecular Formula: C₉H₁₀BrNO₂
• Molecular Weight: 244.09
• Mol File: 207681-67-2.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 352.95°C at 760 mmHg
• Flash Point: 167.258°C
• Appearance: /
• Density: 1.459g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.56
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-BROMO-N-METHOXY-N-METHYLBENZAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-N-METHOXY-N-METHYLBENZAMIDE(207681-67-2)
• EPA Substance Registry System: 3-BROMO-N-METHOXY-N-METHYLBENZAMIDE(207681-67-2)

Safety Data

• Hazardous Substances Data: 207681-67-2(Hazardous Substances Data)

Usage

General Description

3-Bromo-N-methoxy-N-methylbenzamide is a chemical compound with the formula C9H10BrNO2. It is a white to off-white crystalline powder that is used in the synthesis of pharmaceuticals and agrochemicals. 3-BROMO-N-METHOXY-N-METHYLBENZAMIDE is a derivative of benzamide with a bromine atom and a methoxy group attached to the nitrogen and methyl group, respectively. It is known for its use as an intermediate in the production of various drugs, and it is also used as a reagent in organic synthesis. Additionally, it has shown potential as a pesticide and insecticide in agricultural applications. Overall, 3-Bromo-N-methoxy-N-methylbenzamide is a versatile chemical with various industrial and research applications.

InChI:InChI=1/C9H10BrNO2/c1-11(13-2)9(12)7-4-3-5-8(10)6-7/h3-6H,1-2H3

Upstream product

• 108-36-1 1,3-dibromobenzene 
• 1711-09-7 3-bromobenzoyl chloride 
• 1117-97-1 N,0-dimethylhydroxylamine 
• 65-85-0 benzoic acid 
• 6919-61-5 N-methoxy-N-methylbenzamide 
• 98-88-4 benzoyl chloride 
• 585-76-2 m-bromobenzoic acid 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 591-18-4 1-Bromo-3-iodobenzene 
• 201230-82-2 carbon monoxide 

Downstream Products

• 208182-76-7 1-(3-bromophenyl)-2-pyridin-4-ylethane-1,2-dione 
• 208182-72-3 4-[5-(3-bromo-phenyl)-2-(4-chloro-phenyl)-3H-imidazol-4-yl]-pyridine 
• 1237148-49-0 N-Hydroxy-N-{3-[(3-phenylcarbonyl)phenyl]-1-methyl-2-propynyl}urea 
• 207994-95-4 1-(3-bromophenyl)-1-butanone 
• 125997-00-4 1-(3-bromophenyl)pent-4-en-1-one 
• 931430-03-4 1-(3-bromophenyl)-4,4,4-trifluorobutan-1-one 
• 616196-33-9 1-(3-bromophenyl)-2-(2-methylthiopyrimidin-4-yl)-ethanone 
• 1179811-02-9 4-(3-bromobenzoyl)-N,N-diisopropylnicotinamide 
• 655-26-5 m-bromotrifluoroacetone 
• 1208127-07-4 1-(3-bromophenyl)hept-2-yn-1-one 
• 1208127-14-3 3-(3-bromophenyl)-5-butyl-1-methyl-1H-pyrazole 
• 25700-00-9 3-(1H-imidazol-1-yl)acetophenone 
• 25699-97-2 3-(1H-pyrazol-1-yl)acetophenone 

Relevant articles and documents

Rhoda-Electrocatalyzed Bimetallic C?H Oxygenation by Weak O-Coordination

Rhodium-electrocatalyzed arene C?H oxygenation by weakly O-coordinating amides and ketones have been established by bimetallic electrocatalysis. Likewise, diverse dihydrooxazinones were selectively accessed by the judicious choice of current, enabling twofold C?H functionalization. Detailed mechanistic studies by experiment, mass spectroscopy and cyclovoltammetric analysis provided support for an unprecedented electrooxidation-induced C?H activation by a bimetallic rhodium catalysis manifold.

Palladium-Catalyzed, ortho-Selective C-H Halogenation of Benzyl Nitriles, Aryl Weinreb Amides, and Anilides

A palladium-catalyzed, ortho-selective C-H halogenation methodology is reported herein. The highlight of the work is the highly selective C(sp2)-H functionalization of benzyl nitriles in the presence of activated C(sp3)-H bond, which results in good yields of the halogenated products with excellent regioselectivity. Along with benzyl nitriles, aryl Weinreb amides and anilides have been evaluated for the transformation using aprotic conditions. Mechanistic studies yield interesting aspects with respect to the pathway of the reaction and the directing group abilities.

ANTI-HCMV COMPOSITIONS AND METHODS

Novel compounds useful for treating and/or preventing HCMV infections are provided.